| 产品名称 | ReVacc Scientific P40C22 | VSV-Pseudovirus_SARS-CoV-2 Omicron Strain BA.2 Spike with luciferase reporter |
|---|---|
| 目录号 | P40C22 |
| 别名 | VSV-Pseudovirus_SARS-CoV-2 Omicron Strain BA.2 Spike with luciferase reporter |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| P40C22 | 200 μl; 1000 μl | 咨询 | 咨询 |
ReVacc Scientific P40C22 | VSV-Pseudovirus_SARS-CoV-2 Omicron Strain BA.2 Spike with luciferase reporter
品名:VSV-Pseudovirus_SARS-CoV-2 Omicron Strain BA.2 Spike with luciferase reporter
货号:P40C22
品牌:ReVacc Scientific
规格:200 μl; 1000 μl
产品描述
Organism:SARS-Related Coronavirus 2 (virus caused COVID-19), Omicron BA.2 variant.
This pseudotyped virus uses recombinant vesicular stomatitis virus (rVSV) to carry spike protein of SARS-CoV-2 (GenBank: MN908947) with multiple mutations initially identified in variant of Omicron BA.2, including: T19I, LPP24-26del, A27S, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, S477N, T478K, E484A, Q493R, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H, N969K. The spike protein has a 18-aa cytoplasmic tail truncation for optimal infection. As pseudovirus infectivity of rVSV without its original G is restricted to a single round of replication, the pseudotypes can be handled using BSL-2 containment practices. Infection of cells with this pseudotyped virus carrying luciferase reporter results in high level luciferase activity. See our titration result showing that the starting 2-fold diluted pseudovirus generates signal over 100,000-fold higher than uninfected control (cell alone as background in blue). We also evaluated the neutralizing activity of two published control mAbs and one own S2-specific antibody RV6 by using this pseudotyped virus with one (CB6) losing neutralizing activity against this variant. See figure.